Literature DB >> 19237625

Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?

Howard I Scher, Klaus Pantel.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19237625     DOI： 10.1200/JCO.2008.21.2092

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  [What comes after docetaxel?].

Authors:  C-H Ohlmann; M Stöckle
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

Review 2.  [Third generation anti-androgen therapy of advanced prostate cancer].

Authors:  C-H Ohlmann; J Kamradt; M Stöckle
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

Review 3.  Circulating tumors cells as biomarkers: progress toward biomarker qualification.

Authors:  Daniel C Danila; Klaus Pantel; Martin Fleisher; Howard I Scher
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

Review 4.  The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Authors:  William L Harryman; James P Hinton; Cynthia P Rubenstein; Parminder Singh; Raymond B Nagle; Sarah J Parker; Beatrice S Knudsen; Anne E Cress
Journal:  Biochim Biophys Acta       Date:  2016-09-24

Review 5.  [Palliative systemic therapy of castration-resistant prostate cancer: current developments].

Authors:  F Finter; L Rinnab; K Gust; R Küfer
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

6.  Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.

Authors:  Christoph Ausch; Veronika Buxhofer-Ausch; Ulrike Olszewski; Rudolf Schiessel; Emil Ogris; Wolfgang Hinterberger; Gerhard Hamilton
Journal:  J Gastrointest Surg       Date:  2009-09-02       Impact factor: 3.452

Review 7.  Cohesive cancer invasion of the biophysical barrier of smooth muscle.

Authors:  William L Harryman; Kendra D Marr; Daniel Hernandez-Cortes; Raymond B Nagle; Joe G N Garcia; Anne E Cress
Journal:  Cancer Metastasis Rev       Date:  2021-01-04       Impact factor: 9.264
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.